A dose-response relationship was observed, with the highest statin dose quartile (Q4) yielding the greatest dementia risk reduction (IRR 0.36; 95% CI, 0.31 to 0.40), supported by a significant trend (p for trend < 0.0001).
← all excerpts
Statin therapy on dementia in elderly type 2 diabetes patients with delirium.
1
—
—